Article
Neuroendocrine Prostate Cancer: Subtypes, Biology, and Clinical Outcomes
1 May 2014
Abstract excerpt
Neuroendocrine prostate cancer (NEPC) encompasses various clinical contexts, ranging from the de novo presentation of small cell prostatic carcinoma to a treatment-emergent transformed phenotype that arises from typical adenocarcinoma of the prostate. The development of resistance to potent androgen receptor signaling inhibition may be associated with the emergence of aggressive phenotype, advanced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
